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Summary 
The cytosolic yeast proteins Secl3p-Sec31 p, Sec23p- 
Sec24p, and the small GTP-binding protein Sarlp gen- 
erate protein transport vesicles by forming the mem- 
brane coat termed COPII. We demonstrate by thin 
section and immunoelectron microscopy that purified 
COPII components form transport vesicles directly 
from the outer membrane of isolated yeast nuclei. An- 
other set of yeast cytosolic proteins, coatomer and 
Arflp (COPI), also form coated buds and vesicles from 
the nuclear envelope. Formation of COPI-coated, but 
not COPII-coated, buds and vesicles on the nuclear 
envelope is inhibited by the fungal metabolite brefel- 
din A. The two vesicle populations are distinct. How- 
ever, both vesicle types are devoid of endoplasmic 
reticulum (ER) resident proteins, and each contains 
targeting proteins necessary for docking at the Golgi 
complex. Our data suggest that COPI and COPII medi- 
ate separatevesiculartransport pathways from the ER. 
Introduction 
Transport vesicles that mediate protein trafficking be- 
tween successive compartments of the secretory pathway 
can be distinguished both by their unique cargo and by 
the distinct sets of coat proteins that assemble on the 
donor membrane and drive vesicle budding. Formation of 
vesicles in a cell-free assay that reconstitutes intra-Golgi 
protein trafficking in mammalian cells requires only two 
cytosolic components(Orci et al., 1993a): coatomer, a pro- 
tein complex containing seven subunits (a-COP, (j-COP, 
b’-COP, $OP, &COP, E-COP, and <-COP), and the 20 
kDa GTP-binding protein ADP-ribosylation factor 1 (ARFl) 
(for reviews see Rothman and Orci, 1992; Salama and 
Schekman, 1995). These proteins assemble into a non- 
clathrin coat (COPI) that remains associated with the sur- 
face of vesicles generated in the presence of the nonhy- 
drolyzable GTP analog, GTPyS (Rothman and Orci, 1992). 
The COPI components appear to function at several 
stages in the endoplasmic reticulum (ER)-Golgi limb of 
the secretory pathway. Many observations support a role 
for COPI in ER-to-Golgi transport. In mammalian cells, 
coatomer is localized to the cis-Golgi and the transitional 
area between the ER and cis-Golgi network (Duden et 
al., 1991; Oprins et al., 1993) as well as to a specialized 
coatomer-enriched ER structure (CRER), the formation 
of which is enhanced under conditions that reduce ER- 
to-Golgi transport (Orci et al., 1993b, 1994). Additionally, 
immunoinhibition experiments with anti+COP antibodies 
have demonstrated that coatomer is essential for mem- 
brane trafficking from the ER to the Golgi (Pepperkok et 
al., 1993) a step that is also blocked by expression of 
dominant mutants of ARFl in mammalian cells (Dascher 
and Balch, 1994; Zhang et al., 1994). Temperature- 
sensitive ER-to-Golgi trafficking has been observed in mu- 
tant mammalian cells defective in E-COP (Guo et al., 1994) 
and in Saccharomyces cerevisiae mutants defective in 
ARf 7 and coatomer f3-, f3’-, and T-COP subunits (Stearns 
et al., 1990; Hosobuchi et al., 1992; Duden et al., 1994). 
Several yeast coatomer subunits have also been impli- 
cated in retrieval of dilysine-tagged ER resident proteins 
from the Golgi to the ER (Letourneur et al., 1994). Indeed, 
it has been argued that COPI may function exclusively in 
retrograde traffic and that inhibition of COPI function may 
block anterograde traffic indirectly by causing the deple- 
tion of essential targeting proteins (called SNARES) from 
the ER (Pelham, 1994). 
Another set of cytosolic proteins (the Secl3p-Sec31 p 
complex, the Sec23p-Sec24p complex, and Sarl p) have 
been identified that are required for the formation of trans- 
port vesicles that mediate ER-to-Golgi trafficking in yeast 
(Salama et al., 1993). These three components form a 
vesicle protein coat called COPII (Barlowe et al., 1994). 
Homologs of these proteins have been identified in plants 
and mammalian cells (Orci et al., 1991a; d’Enfert et al., 
1992; Kuge et al., 1994; Shaywitzet al., 1995) suggesting 
that COPII-mediated ER-to-Golgi transport is conserved. 
Given the evidence that COPI and COPII both are re- 
quired for protein traffic from the ER to the Golgi complex, 
we sought a direct test of the role of these coat proteins 
in vesicle budding from the ER. Morphological and immu- 
noelectron microscopic (immuno-EM) analysis of a mam- 
malian cell-free system that reproduces intra-Golgi vesi- 
cular transport has been used to examine intermediate 
stages of COPI vesicle biogenesis (Orci et al., 1993a; Ost- 
ermann et al., 1993). In this report, we describe the use 
of yeast nuclei as a morphologically pure source of ER 
membranes to test the capacity of COPI and COPII to 
make vesicles for anterograde transport. We demonstrate 
that each coat can promote vesicle formation from the ER. 
Results 
Vesicle Formation from Isolated Yeast Nuclei 
A cell-free reaction that measures the formation of ER- 
derived vesicles has been described previously (Rexach 
and Schekman, 1991). In brief, vesicle formation is mea- 
sured by quantifying the release of slowly sedimenting 
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Figure 1. Requirements for the Formation of 
COPI- and COPII-Coated Vesicles and Buds 
isolated nuclei were incubated in the pres- 
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ence or absence (minus) of myr-yArf1 p(Ct71 L), 
coatomer, Sarlp, Secl3p-Sec31p, Sec23p- 
Sec24p, and guanine nucleotide. Budding re- 
actions were either processed for standard EM 
or assayed for the release of vesicles con- 
taining [%]gpaF as described in Experimental 
Procedures. The number of coated buds and 
vesicles were quantified on the outer nuclear 
envelope of 40 thin-sectioned nuclei (nuclear 
profiles) per trial and are reported as the mean 
f SEM. The experiments in each row were 
repeated at least twice, and the budding and 
[%]gpaF vesicle release figures for two repeti- 
tions are given. Abbreviation: PNP is GMP- 
PNP. 
protein glycosylated pro-a-factor ([35S]gpaF) from ER 
membranes (Rexach and Schekman, 1991). Either perme- 
abilized yeast spheroplasts or microsomal membranes 
may be used as a source of ER membranes in the cell-free 
assay (Rexach and Schekman, 1991; Wuestehube and 
Schekman, 1992). However, the microsomal membrane 
preparation used in the budding reaction contains other 
organelles and membrane fragments, including mitochon- 
dria, Golgi, and plasma membrane, which complicates the 
characterization of ER vesicle budding by EM. 
We examined the capacity of purified yeast nuclei to 
function in the budding assay. The nuclear envelope is 
contiguous with the rough ER and has been estimated to 
comprise -30% of the rough ER in the cell (Preuss et 
al., 1991). Isolated yeast nuclei (prepared as described 
by Aris and Blobel, 1991) offer several advantages over 
microsomal membranes as a source of ER membranes: 
the large profile of the isolated nucleus may serve to orient 
the image of membrane buds for EM, and nuclear prepara- 
tions may be obtained that are relatively free of other or- 
ganelles and membranes. The amount of Golgi contami- 
nation in the isolated nuclei preparation was estimated by 
assay of the Golgi maker enzyme GDPase (Yanagisawa 
et al., 1990). Of the total cellular GDPase, -2%-40/o was 
recovered in the nuclear fraction, and the corresponding 
specific activity of this enzyme was 4- to g-fold lower than 
in isolated microsomal membranes. 
The requirements for protein translocation and vesicle 
formation from nuclei were similar to those found for other 
sources of yeast ER membranes. Vesicle release required 
GTP (or GMP-PNP), incubation at physiologic tempera- 
ture, and each of the COPII components (Figure 1). The 
efficiency of [%]gpaF packaging by COPII ranged from 
30% to 600/o, which generally was greater than with other 
sources of ER membranes. Nuclear-derived COPII vesi- 
cles are bona fide transport intermediates because they 
were competent to target and fuse with the Golgi appara- 
tus in vitro (data not shown). 
To examine the involvement of coatomer and Arflp in 
the formation of ER-derived transport vesicles, we per- 
formed budding reactions using purified yeast coatomer 
and a dominant activated mutant (Q71L) form of N-myris- 
toylated yeast Arflp (myr-yArflp[Q71 L]) (Kahn et al., 
1995). Release of vesicles containing [%]gpaF was not 
detected from nuclei incubated with coatomer, myr- 
yArf1 p, and GTP in the absence (Figures 1 E-1G) or pres- 
ence of 10 f.rM palmitoyl-coenzyme A (CoA) (a cofactor 
required for release of COPI-coated Golgi-derived vesicles 
(Ostermann et al., 1993; Pfanner et al., 1989)) (data not 
shown). Addition of purified myr-yArflp and yeast coa- 
tomer to reactions containing saturating levels of the 
COPII proteins did not stimulate the extent of vesicle for- 
mation (Figures 1 I and lJ), indicating that the two coats 
do not act synergistically. We also found that the small 
GTP-binding proteins myr-yArf1 p and Sarlp were not 
functionally interchangeable and that coatomer could not 
substitute for either Sec23p-Sec24p or SeclBp-Sec3lp 
in the budding reaction (data not shown). 
COPI and COPII Form Coated Buds and Vesicles 
on the Outer Membrane of the Nuclear Envelope 
Isolated nuclei were incubated under budding conditions 
described above, and thin sections were examined in de- 
tail by transmission EM (Figure 2). The nuclear envelope 
surrounding the dense inner chromatin and nucleoplasm 
encloses numerous smaller cisternal spaces between the 
nuclear pore complexes (see Figure 2F). In contrast with 
nuclei examined by EM in whole-cell preparations, many 
regions of the envelope appeared swollen and distended, 
probably owing to the osmotic shock incurred during cell 
fractionation and in the budding reactions (see below). 
No buds or vesicles were detected on the outer or inner 
membrane of nuclei incubated in the absence of either 
guanine nucleotides or coat proteins (unprimed condi- 
tions) (Figures lA, 2A, 3A, and 3F). 
Buds and vesicles on the outer membrane were visual- 
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Figure 2. Morphological Analysis of Vesicle Budding from Isolated Nuclei 
(A-C) Unprimed (A) and primed (B-C) yeast nuclei on conventional thin sections. Serial sectioning indicates that - 70% of the COPI vesicles and 
- 30% of the COPII vesicles are buds. Up to 80 buds and vesicles can be associated with a single nucleus. lndivrdual vesrcles were considered 
to be associated with a nucleus when separated from the nuclear envelope by CO.1 nm. 
(D-F) Primed nuclei showing buds on the outer membrane at high magnification. The coating of the buds is clearly detectable. The primrng 
conditions are indicated on each panel; nuclear pores are indicated by asterisks. 
Magnifications: (A) 38,400 x ; (B) 31,200 x ; (C) 30,400 x ; (D) 104,800 x ; (E) 108,000 x ; (F) 96,000 x 
ized under conditions that inhibit the shedding of coat pro- 
teins Analogs of GTP such as GTPTS or GMP-PNP sup- 
port the formation of COPII vesicles (Barlowe et al., 1994; 
Oka and Nakano, 1994) (see Figure 1 D), but block vesicle 
coat disassembly (Barlowe et al., 1994). Similarly, ARF- 
GTPyS or dominant activated ARFl(Q71 L) inhibit uncoat- 
ing of Golgi-derived COPI-coated vesicles and lead to ac- 
cumulation of COPI-coated buds and vesicles on Golgi 
stacks (Orci et al., 1993a; Tanigawa et al., 1993). Treat- 
ment of isolated nuclei with purified COPII components 
and GMP-PNP induced the formation of numerous coated 
buds and coated vesicles on the outer membrane (see 
Figure 1 D, 2C, and 2E). Buds and vesicles were not pro- 
duced on the inner membrane. By quantitative EM, the 
appearance of COPII-coated buds and vesicles on the nu- 
clear envelope was reduced to background levels in the 
absence of either Sarl p (see Figure 1 B) or guanine nucleo- 
tide (Figure 3F). The number of coated vesicles and buds 
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Figure 3. BFA Inhibits Formation of ER- 
Derived COPI Vesicles 
Two stage budding reactions were performed 
as follows. Isolated nuclei were preincubated 
in stage 1 in the presence or absence (minus) 
of either of 200 HIM BFA, methanol (which was 
used as a solvent for the BFA stock), or myr- 
yArf1 p(wt) plus GTPyS, as indicated, for 10 min 
at 20°C and chilled before the addition of the 
other reaction components. In stage 2, COPI, 
COPII, 100 pM GTPrS, or 100 NM GMP-PNP 
was added as indicated, and reactions were 
incubated for an additional 20 min at 20%. 
Budding reactions were processed and ana- 
lyzed as described in Figure 1. The results for 
two trials of each experiment are reported. 
I BFA ---t COP11 + GMP-PNP I 1 +a., 28.7 
IO nun I I kO.3 220 
stage 1 Stage 2 i + s.e.m. x 
formed in the presence of GTP (see Figure 1C) was re- 
duced compared with GMP-PNP (see Figure 1 D). Maxi- 
mum release of vesicles containing [%]gpaF requires 
higher levels of Secl3p-Sec31 p and Sec23p-Sec24p in 
the presence of GMP-PNP than with GTP (Barlowe et al., 
1994). However, the appearance of buds and vesicles on 
nuclei incubated with GMP-PNP was constant over a 
range of COPII protein amounts. 
Immuno-EM of cryosections (Figure 4) demonstrated 
that the COPII coat contained Secl3p-Sec3lp (Figure 
4A), Sec23p-Sec24p, and Sarlp, indicating that the pro- 
tein composition of the coat surrounding the buds and 
vesicles on the nuclear envelope is similar to the coat seen 
on purified COPII vesicles synthesized in the presence of 
GMP-PNP (Barlowe et al., 1994). lmmunolabeling was 
detected only on the cytosolic aspect of the outer mem- 
brane of the nuclear envelope. The Secl3p-Sec31 p com- 
plex used in these experiments contained the fusion pro- 
tein Secl3p-dihydrofolate reductase (Secl3p-DHFR), 
which facilitated purification of the complex (Salama et al., 
1993). We used anti-DHFR antibodies to immunolocalize 
Secl3p-DHFR and to demonstrate that Secl3p-Sec31 p 
was specifically recruited to newly formed coated buds 
and vesicles (Figure 4C). In addition, COPII-coated buds 
and vesicles on the outer nuclear membrane contained 
Sec22p, a vesicle V-SNARE (data not shown). Neither coa- 
tomer nor Arfl p was detected by immuno-EM of cryosec- 
tions in COPII-coated buds and vesicles. 
Qualitative and quantitative EM revealed the accumula- 
tion of coated buds and vesicles on nuclei incubated in 
the presence of purified coatomer, dominant activaied 
myr-yArf1 p(Q71 L), and guanine nucleotide (see Figures 
lG, 1 H, 28, and 4D). Similarly, purified wild-type myr- 
yArflp-GTPyS stimulated coated bud and vesicle forma- 
tion on the nuclear envelope to about the same extent as 
myr-yArf1 p(Q71 L)-GTP (see Figure 38). No coated buds 
or vesicles were formed in control incubations containing 
either coatomer alone or myr-yArf1 p alone (see Figures 1 E 
and 1 F) or in the presence of both coatomer and wild-type 
myr-yArf1 p but in the absence of guanine nucleotides (see 
Figure 3A). Immuno-EM of cryosections demonstrated 
that the protein coat surrounding the buds and vesicles 
contained coatomer (Figures 48 and 4D) and myr-yArf1 p 
(data not shown). Although immunolabeling was mainly 
restricted to coated buds and vesicles, we have observed 
areas of concentrated immunolabeling on segments of the 
outer membrane that show no obvious bud-like curvature 
(Figure 4B). These coatomer“patches” may represent pro- 
spective budding sites. The data demonstrate that yeast 
coatomer and myr-yArf1 p can assemble coated vesicles 
directly from the ER without including the secretory cargo 
protein [%]gpaF. Because of its functional and structural 
similarity with the COPI coat on mammalian Golgi-derived 
vesicles, the yeast coatomer/Arflp coat on ER-derived 
vesicles will also be referred to as COPI. 
We considered the possibility that purified COPI and 
COPII may form buds and vesicles on any suitable ex- 
posed membrane. Mitochondria were examined because 
this organelle, like the nuclear envelope, contains two 
membranes, the outer of which is active in protein translo- 
cation. Intact mitochondria were isolated according to the 
method of Daum et al. (1982) and incubated with coat 
proteins and nucleotide. By conventional thin section mi- 
croscopy, we detected no coated buds or vesicles on the 
outer membrane of isolated mitochondria incubated with 
nonhydrolyzable GTP and either purified COPI compo- 
nents or COPII components. Binding of coatomer or 
Secl3p-Sec31 p to the outer mitochondrial membrane 
was also not detected by immuno-EM (data not shown). 
COPI and COPII Buds and Vesicles Are Distinct 
To distinguish whether COPI and COPII assemble around 
a common vesicle or generate two distinct vesicle types, 
we incubated isolated nuclei with a mixture of purified coat 
proteins and GMP-PNP. Double immunolabeling was per- 
formed either on cryosections or directly on samples prior 
to embedding (see Experimental Procedures). COPI- 
coated and COPII-coated buds and vesicles were not dis- 
Formation of ER-Derived COPI and COPII Vesicles 
1167 
Figure 4. Immuno-EM Analysis of COPI and COPII Vesicle Formation on Nuclei 
lmmunolabeled cryosections of primed nuclei. In (B), the immunolabeling on the outer nuclear membrane is distinctly patchy (arrowheads), possibly 
revealing the prospective budding zones. (E) shows the close proximity of positive (arrowheads) and negative (arrows) immunolabeled buds on 
a nucleus primed with both COPI and COPII. The priming condition and the antibody used are indicated on each panel. (6). (D). and (E) are 
labeled with protein A-gold (size of gold is 10 nm); (A) and(C) are labeled with 15 nm gold particles coupled to goat anti-rabbit antibody. Magnifications: 
(A) 34,400 x ; (B) 40,600 x ; (C) 45,600 x ; (D) 56,000 x ; (E) 76,600 x 
tinguishable by conventional morphological examination 
(see Figure 2F). However, double immuno-EM demon- 
strated that coatomer and Sec13p-Sec23p were segre- 
gated (Figure 5). The quantitative evaluation of 100 coated 
vesicles and buds revealed that <P/O of the coated buds 
and vesicles generated on the outer nuclear membrane in 
the presence of COPI and COPII labeled with both Sec21 p 
and Secl3p. These results indicate that COPI and COPII 
generate two distinct populations of ER-derived vesicles. 
Brefeldin A Inhibits Formation of COPI-Coated 
Buds and Vesicles 
Brefeldin A (BFA) inhibits an ARF nucleotide exchange 
factor and blocks COPI bud formation and protein trans- 
port within the Golgi complex (Orci et al., 1991b; Don- 
aldson et al., 1992b; Helms and Rothman, 1992) and pro- 
tein transport early in the secretory pathway in yeast 
(Graham et al., 1993; Vogel et al., 1993). If COPI vesicle 
budding from the ER reflects a genuine aspect of the role of 
coatomer in membrane traffic, then the nuclear membrane 
should be sensitive to BFA. We examined the effect of 
BFA on COPI- and COPII-mediated ER vesicle formation. 
BFA did not inhibit the formation or release of [%]gpaF 
containing COPII vesicles (see Figure 31); however, it re- 
duced the number of COPI-coated buds and vesicles on 
the nuclear envelope to background levels (see Figure 
Cell 
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Figure 5. Double lmmunolocalization of COPI 
and COPII Coats on Vesicles and Buds 
The emergence of COPI-or COPII-coated buds 
at separate sites on the outer membrane. The 
arrow in (A) and (B) indicates a grazing view 
of an immunolabeled bud. The inset in (6) also 
shows a grazing view of two labeled structures 
that become bona fide membrane-bounded 
buds/vesicles in the next consecutive section 
(inset in [A]). The priming condition and anti- 
bodies used are indicated on each panel. (A) 
lmmunolabelingofacryosection. (B)Thin cryo- 
section from samples immunolabeled before 
embedding (preembedding labeling tech- 
nique). Sec2lp-Myc, 5 nm gold; SeclBp or 
Sec23p , 15 nm gold. Magnifications: (A) 
92,800 x ; (B) 98,000 x ; (insets) 76,000 x 
30). BFA had no effect when myr-yArf1 p and GTPyS were 
added first (see Figure 3E). These results suggest that the 
outer nuclear membrane contains an Arfl p-specific nucleo- 
tide exchange protein whose action is blocked by BFA. 
Isolation and Characterization of COPI Vesicles 
We developed a method to isolate COPI and COPII vesi- 
cles produced from isolated nuclei. Coated vesicles were 
synthesized in separate large-scale budding reactions in 
the presence of nonhydrolyzable GTP analogs and puri- 
fied by flotation in sucrose density gradients. Addition of 
palmitoyCCoA reduced the number of COPI buds on the 
nuclear membrane and enhanced the recovery of COPI 
vesicles, but it did not affect the exclusive sorting and 
packaging of [35S]gpaF into COPII vesicles (data not 
shown). lmmunoblot analysis of fractions from the flotation 
gradients is shown in Figure 6. COPI- and COPllgenerated 
membranes, marked by Sec21 p-Myc or Sec23p, respec- 
tively, peaked between 40% and 46% (w/w) sucrose (Fig- 
ures 6B and 6C). The peak of Sec23p was coincident with 
the peak of [35S]gpaF in COPII vesicles, indicating that the 
protein coat remains associated with the vesicles under 
these gradient conditions. Flotation of SecPl p-Myc was 
dependent upon the presence of donor membranes, coa- 
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Figure 6. Purification of Nuclear Envelope-Derived COPI- and COPII- 
Coated Vesicles 
Vesicles formed in vitro were resolved from donor membranes and 
soluble components used in therr synthesis by flotatron on sucrose 
densrty gradients. A 14,000 x g supernatant generated from prepara- 
trve scale budding reactions containing COPI (coatomer with Sec21 p- 
Myc and myr-yArflp[wt]) menus GTPyS (A), COPI plus GTP$S (B), or 
COPll and GMP-PNP (C) was concentrated and floated by centrifuga- 
tion at 237,000 x g. Aliquots of gradient fractions (12.5 nl) were re- 
solved on 12.5% SDS-polyacrylamide gels and analyzed by immu- 
noblotting. Lane N contains - 0.05% of input nuclei in each large-scale 
budding reaction. Sec21 p-Myc (coatomer) was detected using mouse 
anti-Myc antibodres (9ElO). Sound anti-Myc and antibodies directed 
against the resident ER protein Sec61 p, Sec23p (COPII), and Sec22p 
were visualized by enhanced chemiluminescence (ECL) (Amersham). 
lmmunoblots A and S were exposed simultaneously to film for 2 min. 
The nuclear proteins that cross-react with anti-Myc antibodies (lane 
N in [A] and [B]) are not specific to Sec21 p-Myc and were not routinely 
seen (see Figure 7A). (C)was exposed for 30 s. The direction of vesicle 
movement during centrifugation is indicated by the arrow. 
tomer and myr-yArf1 p, and guanine nucleotides (GTPrS) 
(Figure 6A) in the budding reaction. 
COPII vesicles contain the integral vesicle protein Sec22p 
(Barlowe et al., 1994; Rexach et al., 1994), a V-SNARE 
that presumably functions in vesicle targeting and fusion 
with the Golgi (Segaard et al., 1994). Both COPI and COPII 
vesicle fractions contained Sec22p based on immunoblot 
(Figures 6B and 6C) and quantitative immuno-EM (Table 
1). A very low background of Sec22p was detected in a 
control gradient prepared from a reaction lacking only 
GTPyS (Figure 6A). Two other ER membrane proteins in- 
volved in vesicle targeting, Betlp and Boslp (Lian and 
Ferro-Novick, 1993; Newman et al., 1992), were also pack- 
aged in both COPI and COPII vesicles that float to 400/o- 
45% (w/w) sucrose (Figure 7A). In contrast, only low levels 
of an early Golgi marker protein, Ochlp (Nakayama et 
al., 1992) were found in the vesicle fractions. Sec61 p, an 
integral ER membrane protein (Stirling et al., 1992), was 
not present in either coated vesicle fractions (Figures 6 
and 7A). Other ER resident proteins, such as Secl2p (data 
not shown) and KarPp (BiP), an ER lumenal Hsc70 (Figure 
7A), were also not detected at significant levels in the vesi- 
cles, indicating that both coats are selective and exclude 
ER resident proteins. 
The peak fractions containing Sec22p generated either 
with COPI or COPII were pooled and centrifuged at 
100,000 x g to concentrate the membranes, which were 
examined by conventional thin section EM and im- 
muno-EM of cryosections. Representative fields of the pel- 
lets reveal mostly uniform populations of coated vesicles 
(see Figures 8A and 88). The diameter of COPI vesicles 
(measured across the outer leaflet of the membrane, coat 
excluded) is 65 + 11 nm (standard deviation) (n = 300 
vesicles measured), and that of the purified COPII vesicles 
is 64 f 10 nm (standard deviation) (n = 300). Larger 
membrane vacuoles/sacs were found as contaminants in 
both coated vesicle preparations. These contaminating 
membranes, but not coated vesicles, were also seen in 
membrane pellets from control gradients (minus GTPrS) 
and in fractions from the sucrose gradients preceding the 
vesicle peak (corresponding to 350/o-40% [w/w] sucrose). 
Immuno-EM of cryosections confirmed that the COPI vesi- 
cle coat contained coatomer and Arfl p (Figures 9A and 
9C; Table 1) and that the COPII coat contained Sarlp 
and Secl3p (Figures 9F and 9H; Table 1). No significant 
labeling of COPI proteins was observed on COPII-coated 
vesicles or vice versa (Figures 9B, 9D, 9E, and 9G). Quan- 
titative double immuno-EM analysis of coated vesicles 
Table 1. Density of Coat Proteins and Sec22p rn Purified ER-Derived Vesicles 
Vesrcle Type Density” 
Coatomer Arfl p Secl3p Sarl p Sec22p 
COPI 197 k 16(238) 117 * lO(218) 5 f 2 (166) 2 f 1 (175) 32 e 6 (209) 
COPII 2 k 1 (204) 3 -c 1 (165) 218 2 9 (226) 64 r+ 7 (225) 98 2 8 (194) 
Shown is the mean f SEM. The number of vesicles analyzed in each condition from five drfferent fields of the pellet is indrcated in parentheses 
For the conditions of rmmunolabeling. see Experimental Procedures Approxrmately 29% of the COPI-coated vesicles and 54% of the COPII-coated 
vesicles were rmmunopositive for Sec22p. Examples of immunolabeled vesicles are shown in Figure 9 
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Figure 7. lmmunoblot Analysis of Gradient-Purified COPI- and COPII- 
Coated Vesicles 
(A) lmmunoblots of vesicles synthesized in the presence of COPI com- 
ponents plus GTPyS (lane 1) or COPII components with GMP-PNP 
(lane 2). Lane N contains - 0.05% of input membranes (5 pg of nuclei) 
used for the vesicle synthesis reactions. The peak vesicle containing 
fractions (40%-45% [w/w] sucrose) from sucrose flotation gradients 
(see Figure 6) were pooled and concentrated by TCA precipitation. 
Equivalent amounts of COPI and COPII membrane samples (based 
upon micrograms of donor membranes in the preparative scale bud- 
ding reaction) were resolved on 12.5% SDS-polyacrylamide gels, 
transferred to nitrocellulose, and analyzed by immunoblotting with anti- 
bodies against Myc, Sec23p, KaRp, Ochlp, SecGlp, Boslp, Sec22p, 
and Bet1 p. The immunoblot was developed by the ECL method (Amer- 
sham) and exposed to film for -25 a.. 
(B) Silver-stained polyacrylamide gel of Nycodenz gradient-purified 
vesicles synthesized in the presence of COPI minus GTPyS (lane l), 
COPI plus GTPyS (lane 2), or COPII with GMP-PNP (lane 3). Purified 
COPI proteins (coatomer [30 ng]) and purified COPII proteins (Secl3p- 
Sec3lp [lo ng], Sec23p-Sec24p [lo ng]) are shown in lanes I and II, 
respectively. Note that the 35 kDa and 25 kDa coatomer subunits are 
not visible in this exposure and that the 200 kDa polypeptide in lane I 
is a contaminant in the purified coatomer preparation. Lane N contains 
-0.025% of input membranes (2.5 pg of nuclei) used for the vesicle 
synthesis reactions. The peak vesicle fractions from Nycodenz flota- 
tion gradients (see Experimental Procedures) were pooled and con- 
centrated by TCA precipitation. Proteins were resolved by 10% SDS- 
PAGE and silver stained. Vesicle proteins corresponding to COPI sub- 
units and COPII subunits are indicated by a closed diamond and a 
closed circle, respectively. Several unique COPI (asterisk) and COPII 
(plus) vesicle polypeptides are indicated. 
generated in the presence of a mixture of COPI and COPII 
purified proteins showed that each vesicle species was 
surrounded by only one coat type (data not shown), sup- 
porting the conclusion that there was no intermixing of 
these two distinct sets of coat proteins. 
To determine the relative amounts of COPI and COPII 
vesicles formed in vitro, we compared the values obtained 
by quantitative immuno-EM of Sec22p (Table 1) with 
amounts measured by quantitative immunoblotting of iso- 
lated vesicle fractions generated by each coat; -6- to 
8-fold more Sec22p was found in vesicle fractions gener- 
ated with COPII than with COPI (data not shown). Based 
upon the 3-fold difference in the specific labeling density 
of Sec22p content (Table l), we estimate that COPII gener- 
ates 2- to 3-fold more vesicles than COPI. 
For SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) and silver staining analysis of the less abundant 
vesicle membrane proteins, we chose purification condi- 
tions that reduce the level of coat proteins in the final vesi- 
cle preparation (see Figure 78). Vesicles were generated 
in large-scale budding reactions and concentrated by sedi- 
mentation to equilibrium on a linear sucrose/D20 gradient. 
Both coated vesicle species were made with equal efficien- 
cies in the presence of either GTP or the nonhydrolyzable 
GTP analogs and were equilibrated on the sucrose/D20 
gradients at densities equivalent to 28% (w/w) sucrose 
and 29% (w/w) sucrose, respectively. Coated vesicles 
were then floated to equilibrium in Nycodenz densitygradi- 
ents under conditions that have previously been shown 
to disrupt the COPII coat (Barlowe et al., 1994). COPI- 
generated vesicles (marked by Sec22p) and COPII- 
generated vesicles (marked by Sec22p and 135]gpaF) 
equilibratedon the Nycodenzgradientsat densitiesof 1.13 
g/ml and 1.12 g/ml, respectively. By silver stain analysis, 
we detected a number of polypeptides (distinct from either 
the COPI or COPII coat proteins) common to the two prep- 
arations (see Figure 78). In addition, several major and 
minor polypeptides were found to be unique to either COPI 
or COPII vesicles (compare lanes 2 and 3 in Figure 78). 
Discussion 
Genetic, morphological, and biochemical evidence sup- 
ports roles for COPI and COPII in membrane and protein 
traffic between the ER and the Golgi complex. Our previ- 
ous work on this subject suggested that COPII, but not 
COPI, is primarily responsible for cargo selection and 
packaging from the ER (Barlowe et al., 1994). However, 
given the crude membrane fraction typically employed in 
the cell-free ER-to-Golgi transport reactions, it was not 
possible to conclude with any certainty that COPII formed 
vesicles directly from the ER as opposed to budding cargo 
from some intermediate compartment downstream of the 
ER. For this reason, nuclei were used as a source of bona 
fide ER membranes, and, as shown in this report, these 
membranes are even more active in COPII-mediated vesi- 
cle budding than crude membranes. Even more important- 
ly, we observe profiles of budding intermediates formed 
exclusively on the outer membrane of nuclei only when 
all three COPII proteins and nucleotide are present in an 
incubation. 
In contrast with the clear role of COPII in budding from 
the ER, the function of the COPI coat has been a matter 
of controversy(Pelham, 1994). COPI, which was originally 
identified as the coat surrounding vesicles that form in an 
intraQolgi transport reaction, has also been implicated in 
Formation of W-Derived COPI and COPII Vesicles 
1191 
Figure 8. Conventional Thin Sections of Puri- 
fied COPI and COPII Vesicles 
(A) COPI. (6) COPII. Both fractions contain a 
few large nonvesicle membrane contaminants. 
The insets detail the morphology of each type 
of coated vesicle. Magnifications: (A and B) 
55,200x ; (inset of [A]) 104,000 x ; (inset of [B]) 
78,400 x 
anterograde and retrograde traffic between the ER and 
Golgi. A role of COPI in retrograde budding is supported 
by the observation that coatomer subunits (a and y) can 
be mutated to forms that fail to retrieve dilysine-tagged ER 
membrane proteins from the Golgi complex (Letourneur et 
al., 1994). Such mutants (ret) are conditionally lethal, yet 
have no effect on secretion. ret mutants may specifically 
cripple the interaction of coatomer with the dilysine re- 
trieval motif while retaining the ability to assemble COPI 
coats and vesicles for anterograde transport. This view is 
supported by the fact that sec27-7, a restrictive allele of 
they coatomer subunit, is defective in both secretion and 
retrieval (Hosobuchi et al., 1992; Letourneur et al., 1994). 
If COPI were involved exclusively in retrograde traffic, 
there would be no reason for it to be recruited to the ER 
to bud vesicles for anterograde transport. In contrast, we 
observe significant budding of COPI vesicles from the nu- 
clear envelope. COPI and COPII vesicles form indepen- 
dently on the nuclear membrane; each employs a distinct 
GTP-binding protein and integral membrane nucleotide 
exchange factor. COPII depends on Secl2p, an ER mem- 
brane glycoprotein that facilitates nucleotide exchange 
on Sarl p, but that is not itself packaged into COPII vesi- 
cles (Barlowe et al., 1994). COPI requires an as-yet- 
uncharacterized nucleotide exchange factor that promotes 
the activation of ARF. BFA blocks the action of this ex- 
change factor and thereby prevents the recruitment of 
ARF and coatomer to membranes engaged in COPI vesi- 
cle formation (Donaldson et al., 1992a, 1992b; Helms and 
Rothman, 1992). Significantly, we observe that COPI but 
not COPII bud formation on nuclear membranes is BFA 
sensitive. Thus, the ARF nucleotide exchange factor must 
be present on the ER membrane, and we argue that it is 
there to serve a role in some form of anterograde transport 
mediated by COPI. Although Secl2p does not facilitate 
nucleotide exchange by ARF (Barlowe and Schekman, 
1993), Sed4p, a homolog of Secl2p (Hardwick et al., 
1992), may serve this function in COPI-mediated traffic. 
COPI and COPII budding profiles on the nuclear mem- 
brane are enhanced when a nonhydrolyzable analog, 
GMP-PNP, is used in place of GTP. Nonhydrolyzableana- 
logs of GTP prevent recycling of the GTP-binding protein 
and result in retention of Sarlp and Arflp in the coated 
vesicle. The elevated levels of the GTP-binding proteins 
in the vesicle coat could retard efficient vesicle release 
from the membrane. Alternatively, the fission reaction that 
cleaves a bud from the donor membrane is stimulated by 
hydrolysis of GTP by GTP-binding protein. The compara- 
ble reaction in completion of budding by COPI on Golgi 
cisternae requires palmitoyl-CoA (Ostermann et al., 1993; 
Pfanner et al., 1989); this requirement is not shared by 
the COPII-mediated process. 
Coatomer and ARF are associated with ER membranes 
in other organisms. A significant fraction of coatomer is 
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Figure 9. lmmunolabeling of Nuclear-Derived Coated Vesicles 
The priming condition and the antibody used are indicated on each panel. Protein A-gold labeling of cryosections, 10 nm gold. See Table 1 for 
quantitation. Magnification: (A-H) 60,600x. 
associated with a domain of the ER, the CRER, adjacent to 
but not coincident with the classical ER-Golgi transitional 
zone (Orci et al., 1994). Thus, in mammalian cells, the 
COPI and COPII anterograde pathways may be physically 
segregated with CRER, serving to generate COPI vesicles 
and the transitional zone specializing in COPII budding. 
Such regional differentiation may exist in the yeast ER, but 
be difficult to recognize for lack of suitable morphological 
landmarks. Recruitment of ARF to nuclear membrane ves- 
icles has been documented in Xenopus, where GTPyS 
blocks the fusion of envelopevesicles that are responsible 
for reassembly of the nucleus in telophase (Boman et al., 
1992). 
COPI and COPII may be compared and contrasted in 
the kinds of cargo molecules that they capture or exclude 
in buds. In both cases, resident ER proteins such as 
Secl2p, Sec61 p, and KaRp (BiP) are excluded from vesi- 
cles. These proteins may lack positive sorting information 
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for anterograde movement or possess retention signals 
that hinder packaging. In either case, resident proteins 
escape at a slow rate to the Golgi and must be returned 
to the ER, which for certain proteins occurs by a positive 
retrieval signal (Rothman and Orci, 1992). Because COPI 
probably carries escaped BiP back from the Golgi, the 
rules that govern its capture in retrograde and anterograde 
vesicles must differ. Perhaps a pH or ionic difference be- 
tween the ER and Golgi allows COPI in one case to favor 
and in the other to exclude cargo or recycling molecules. 
Both coats capture proteins required for vesicle tar- 
geting. The V-SNARE molecules Sec22p, Bosl p, and 
Betlp are found in COPI and COPII vesicles, though the 
densitv of Sec22o is 3- to 4-fold qreater in COPII vesicles. 
SNARi proteins’ expose significant N-terminal polar do- 
mains on the cytosolic face of the ER, and we suggest 
thattheymayshareasimplesequenceorfold thatisrecog- 
nized and binds a cognate subunit of COPI and COPII. The 
same signal may be recognized for retrieval of v-SNARES 
back to the ER. COPI alone may execute retrieval because 
Secl2p, and thus Sarl p and COPII maintain no apprecia- 
marcate the anterograde and retrograde processes. A pre- 
diction of our model is that membrane proteins essential 
to retrograde transport will continue to cycle between the 
ER and Golgi complex in COPII mutant cells, but will fail 
to cycle in COPI mutant cells. We have identified several 
proteinsspecific to COPI vesicles. Purification and charac- 
terization of these vesicle proteins will allow an assess- 
ment of the role of COPI in forward vesicle trafficking. 
Experimental Procedures 
Materials 
All reagents, unless specified, were from Sigma. Preparation of the 
purified COPII components has previously been described (Salama 
et al., 1993; Barlowe et al., 1994). Escherichia coli BLZl(DE3) strains, 
which coexpress yeast N-myristoyltransferase and either wild-type or 
dominant activated yeast Arflp, were provided by R. Kahn (National 
Institutes of Health). N-myr-yArflp(wt) and N-myr-yArflp(Q71L) were 
purified as described previously (Kahn et al., 1995). Electrospray- 
ionization mass spectrometty (Hewlett-Packard 5989A) was used to con- 
firm that 275% of the E. coli expressed yArflp(wt) and yArflp(Q71L) 
were myristoylated as judged by the expected 210.4 amu increase in 
mass over the nonmyristoylated species (D. King, personal communi- 
cation). Purified yeast coatomer complex containing a Myc-tagged 
ble residence on the Golgi complex (Orci et al., 1991a; 
vesicle proteins may be recruited by either coat, as sug- 
gested by the detection of a number of unidentified poly- 
peptides common to COPI and COPII vesicles. 
Kuoe et al.. 1994). In addition to the V-SNARES, other 
The coats differ in their recognition of cargo molecules. 
a-Factor precursor, the molecule we use to represent se- 
cretory traffic, is packaged exclusively by COPII vesicles. 
Plasma membrane precursor proteins, such as a major 
GPI-linked yeast cell surface protein, Gaslp (Doering and 
Schekman, 1996), and two amino acid permeases, Hip1 p 
and Gaplp (M. t&ehn and R. S., unpublished data), also 
are packaged by COPII. Our data are therefore not consis- 
tent with the idea that secretory proteins pour out of the 
ER by bulk flow. Indeed, secretory and membrane proteins 
appear to be concentrated at the point of exit from the ER 
(Balch et al., 1994; Mizuno and Singer, 1993). The COPS 
may provide a means to concentrate and select cargo 
molecules that are d&lined for transport. Lumenal pro- 
teins may be enriched within COP vesicles by indirect con- 
tact with the coat through membrane adapters that display 
a cytosolic domain suitable for activation. One such mem- 
brane adapter may be Emp24p, recently detected in COPII 
vesicles and shown by genetic analysis to enhance the 
rate of transit of a subset of secretory proteins from the 
ER (Schimmoller et al., 1995). We predict that a subset of 
ER membrane proteins will recruit Sarl p-GTP, Secl3p- 
SecBlp, and Sec23p-Sec24p and that a separate, per- 
haps smaller, subset will recruit ARF-GTP and coatomer, 
whereas the majority representing resident membrane 
proteins will associate with neither coat. 
375~P::SEC21::c-myc)cytosol as described by Hosobuchi et al. (1992). 
SecPlp(y)subunitwaspreparedfromRSY 1016(MATa, sec27::TRPI, 
Antibodiesagainst c-Myc, Sec23p, Secl3p. DHFR, Sarlp, SecGlp, 
Bet1 p. yeast coatomer, Sec2lp, and KarPp have previously been de- 
ura3-52, leu2A1, lys 2-601, ade 2-101, trp 1663, his 34200, pRS- 
scribed (Evan et al.. 1985; Hosobuchi et al., 1992; Salamaet al., 1993; 
Barlowe et al., 1994; Rexach et al., 1994). Antibodies against Boslp, 
yArflp (R40), and Ochlp were provided by J. E. Rothman, R. Kahn, 
and Y. Jigami, respectively. Polyclonal antibodies to Sec22p were 
raised against purified E. coli expressed glutathione S-transferase- 
Sec22p (amino acids 2-120) fusion protein. Goat anti-mouse IgG cou- 
pied to 5 nm or 10 nm gold particles and goat anti-rabbit IgG coupled 
to 6 nm or 15 nm gold were purchased either from Aurion or Amersham 
Life Science. 
Methods for trichloroactetic acid (TCA) precipitation (Bensadoun 
and Weinstein, 1976), SDS-PAGE (Laemmll, 1970), silver staining 
(Bloom et al.. 1987). immunoblottina (Towbin et al., 1979). and immu- 
~ 
- 
nodetection by enhanced chemlluminescence(Amersham) have been 
described elsewhere. 
Preparation of Yeast Membranes 
Nuclei were isolated from RSY445 (leu 2-3.172; ura 3-52; rrpl-289; 
prbl; pep4::URAS; ga/2; his 4-579; MATa). Cells were grown In YPD 
(2% Bacto peptone [Difco Laboratories], 1% Bacto yeast extract 
[Difco], and 2% dextrose) at 30°C to early log phase (3-5 OD&ml) 
and converted into spheroplasts as previously described (Rexach et 
al., 1994). Spheroplast lysis and nuclei isolation were performed es- 
sentially as described by Aris and Blobel(1991), with only minor modifl- 
cations. Nuclei were stored at 2 mglml in B88-glycerol(50% [v/v] glyc- 
erol, 20 mM HEPES-KOH [pH 6.81, 250 mM Sorbitol, 150 mM KOAc, 
5 mM Mg(OAC),) at -2OOC. Protein concentration was determined by 
the DC protein assay (Bio-Rad) or by measuring the AzsO of a 1:200 
dilution in 2% (w/v) SDS (1 .O A&ml is 44.5 mglml). Typically, 30 mg 
of nuclei were isolated from 40,000 OD600 of cells, and the membranes 
remained active for [35S]methionine-prepro-a-factor ([35S]ppaF) trans- 
location and COPII vesicle formation for at least 2 months of storage 
Isolated yeast mitochondria were supplied by J. Nunnari (University 
of California, San Francisco) Mitochondria were prepared from W303 
pep4::TRPl strain as described by Daum et al. (1982) and stored at 
-8OOC In 0.6 M sorbitol, 50 mM HEPES-KOH, (pH 7.4). 10% BSA. 
10% DMSO 
Assuming COPII is responsible for transport of the ma- 
jority of secretory and membrane cargo molecules, what 
function does COPI serve in anterograde traffic? One pos- 
sibilitv is that COPI returns to the cis-Golgi cisterna mem- 
bran; proteins such as the ARF nucleotide exchange fac- 
tor and retrograde-specific proteins that are necessary to 
sustain the retrograde pathway. It may be necessary to 
keep these molecules out of COPII vesicles so as to de- 
Vesicle Budding Assay 
Budding reactlons contained the following concentrations of purified 
COPI and/or COPII components: 8 pg/ml Sarlp, 8 pglml Sec23p- 
Sec24p, 50-100 pg/ml SeclSp-Sec3lp, 8-16 pg/ml myr-yArflp, and 
20-50 Kg/ml coatomer. Guanine nucleotides (100 PM final), palmitoyl- 
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CoA (10 PM final), and an ATP regeneration system (Baker et al., 
1988) were added to the reactions as indicated in the text. For stage 
two assays, BFA (Epicentre Technologies) was added from a 25 mM 
stock in methanol; control reactions were supplemented with an equal 
volume of methanol as indicated. The concentration of nuclei in 25 frl 
analytical and 2.0 ml preparative scale vesicle production reactions 
were 0.8 mg/ml and 5.0 mg/ml, respectively. The concentration of 
mitochondria was 100 ug per 25 frl reaction. [35S]ppaF was posttransla- 
tionally translocated into the envelope of isolated nuclei as previously 
described by Wuestehube and Schekman (1992) for ER-enriched 
yeast microsomes. Nuclei and mitochondria were incubated with puri- 
fied COPI and/or COPII components at 20°C for 25 min and chilled 
on ice for 5 min. Vesicles were separated from donor membranes 
by centrifugation at 14,000 x g in a Tomy microcentrifuge. Release 
of [35S]gpuF containing vesicles was quantified by determining the 
amount of protease protected [35S]gpaF contained in the 14,000 x g 
supernatant as previously described (Rexach and Schekman, 1991). 
Vesicle chase to the Golgi complex was determined as previously 
described (Barlowe et al., 1994). 
COPI- and COPII-Coated Vesicle Isolation 
The 14,000 x g supernatant from a 2.0 ml preparative scale budding 
reaction was treated with 150 pglml RNase A for 30 min at 20°C to 
reduce the level of ribosome contamination in the vesicle preparation 
and recentrifuged at 14,000 x g. Membranes were concentrated by 
sedimentation at 50,000 rpm (237,000 x g) for 2 hr in a Beckman 
SW55.1 rotor through 2.5 ml of 15% (w/w) sucrose in 688 step onto 
a 70% (w/w) sucrose pad. The 15%-70% (w/w) sucrose interface was 
collected, adjusted to 55% (w/w) sucrose in B88, and overlaid with 
0.5 ml steps of 52.5%, 50%, 45%, and 1.0 ml steps of 40%, 35%, 
and 25% (w/w) sucrose in 688. The gradient was centrifuged at 50,000 
rpm at 4°C in a SW55.1 rotor for 16 hr, and 17 x 0.3 ml fractions 
were collected from the top. 
For silver stain analysis of total vesicle proteins, 2 ml of RNase 
A-treated 14,000 x g supernatant was layered over a linear 3 ml 
sucrose/D20 gradient (prepared by layering 0.5 ml aliquots of 5%, 
lo%, 20%, 30%, 40%, and 50% [w/w] sucrose, dissolved in 8881 
D,O, and allowed to stand at 4OC overnight) and centrifuged for 3 hr 
at 50,000 rpm in a SW551 rotor. The peaks of Sec22p and ?S]gpuF 
containing COPI- and COPII-coated membranes were adjusted to 50% 
(w/v) Nycodenz by adding 80% (w/v) Nycodenz dissolved in B88 (final 
volume, - 1 ml) and overlaid with 0.7 ml aliquots of 40%, 35%, 30%, 
25%, 20%, and 15% (w/v) Nycodenz in 888 and centrifuged at 50,000 
rpm at 4°C in a Beckman SW55.1 rotor for 16 hr. Fractions (17 x 0.3 
ml) were collected from the top. The GDPase activity (Yanagisawa et 
al., 1990) refractive index, and PS]gpaF content of each gradient 
fraction were assayed. 
EM and lmmunocytochemistry 
Budding reactions containing nuclei or mitochondria were fixed for 
30 min in 1.5% glutaraldehyde (Ted Pella, Incorporated). Nuclei and 
mitochondria were sedimented at 3000 x g and 14,000 x g, respec- 
tively, for 5 min in a refrigerated microcentrifuge. Gradient-purified 
COPI and COPII vesicle fractions from sucrose flotation gradients were 
diluted 3-fold with B88 and fixed in 1% glutaraldehyde for 30 min at 
4OC and concentrated by centrifugation at 100,000 x g. For conven- 
tional EM, samples of the pellet were processed as previously de- 
scribed (Orci et al., 1991b). For immunocytochemistry, fragments of 
the fixed pellet of nuclei or vesicles were infiltrated with 2.3 M sucrose 
and processed for cryoultramicrotomy (Tokuyasu, 1986). Immunolo- 
calization on cryosections was carried out by the protein A-gold tech- 
nique (Roth et al., 1978) or by using goat anti-rabbit or goat anti-mouse 
IgG coupled to gold particles. 
For preembedding immunolabeling, budding reactions were fixed 
for 1 hr with 3.0% paraformaldehyde and 0.2% glutaraldehyde. Nuclei 
were washed for 30 min with PBS (pi-i 7.4) containing 250 mM sorbitol, 
1% (w/v) BSA, and 10 mM glycine and then incubated overnight at 4OC 
with a mixture of primary antibodies (rabbit antiSec23p and mouse 
anti-Myc) or with PBS. After washing with 250 mM sorbitol, 1% BSA 
in PBS (pH 7.4) nuclei were immunolabeled with a mixture of 15 nm 
goat rabbit IgG gold and 5 nm goat anti-mouse IgG gold for several 
hours at 4°C washed, and fixed with 1.5% glutaraldehyde for 1 hr. 
The pellets were postfixed with osmium tetroxide, stained en bloc with 
uranyf acetate (Tandler, 1990) dehydrated, and embedded in Epon. 
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